Multidrug-resistant and extensively drug-resistant tuberculosis: The new face of an old disease

Journal of the American Academy of Nurse Practitioners

Volumn 21, Issue 11, 2009, Pages 603-609

  Ferguson, Laurie Anne ^a   Rhoads, Jacqueline ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Extensively drug resistant TB (XDR TB); Multidrug resistant TB (MDR TB); Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; DIRECTLY OBSERVED THERAPY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HEALTH SURVEY; HUMAN; MULTIDRUG RESISTANCE; PUBLIC HEALTH; TUBERCULIN TEST;

ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; POPULATION SURVEILLANCE; PUBLIC HEALTH; TUBERCULIN TEST;

EID: 71049177770     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2009.00458.x     Document Type: Article

References (22)

1. Abou-Raya, S., & Abou-Raya, A. (2006). Spinal tuberculosis: Overlooked? Journal of Internal Medicine, 260, 160 163.
2. American Lung Association 2007). Tuberculosis morbidity and mortality. Retrieved January 6, 2008, from http://www.lungusa.org/atf/cf/%7B7A8D42C2-FCCA- 4604-8ADE-7F5D5E762256%7D/TREND-TB-APRIL2007.PDF
3. Cain, K. P., Haley, C. A., Armstrong, L. R., Garman, K. N., Wells, C. D., Lademarco, M. F., et al. (2007). Tuberculosis among foreign-born persons in the United States. American Journal of Respiratory Critical Care Medicine, 175, 75 79.
4. Diwakar, L. (2006). Low back pain-think of tuberculosis. Letter. British Medical Journal, 333, 201.
5. Doherty, T. M., & Rook, G. (2006). Progress and hindrances in tuberculosis vaccine development. Lancet, 367, 947 949.
6. Hopewell, P. C., Pai, M., Maher, D., Uplekar, M., & Raviglione, M. C. (2006). International Standards for Tuberculosis Care. Lancet Infectious Diseases, 6, 710 725.
7. Jassal, M., & Bishai, W. R. (2009). Extensively drug-resistant tuberculosis. Lancet Infectious Disease, 9, 19 30.
8. Kim, H. R., Hwang, S. S., Kim, H. J., Lee, S. M., Yoo, C. G., Kim, Y. W., et al. (2007). Impact of extensive drug resistance on treatment outcomes in non-HIV infected patients with multidrug-resistant tuberculosis. Clinical Infectious Diseases, 45, 1290 1295.
9. Lalvani, A. (2007). Diagnosing tuberculosis infection in the 21st century: New tools to tackle and old enemy. Chest, 131, 1898 1906.
10. Migrant Clinicians Network. TBNet. Retrieved May 30, 2008, from http://www.migrantclinician.org/clinical-topics/tuberculosis.html
11. Mukherjee, J. S., Rich, M. L., Socci, A. R., Joseph, J. K., Virú, F. A., Shin, S. S., et al. (2004). Programs and principles in treatment of multidrug-resistant tuberculosis. Lancet, 363, 474 481.
12. Nahid, P., Pai, M., & Hopewell, P. C. (2006). Advances in the diagnosis and treatment of tuberculosis. Proceedings of the American Thoracic Society, 3, 103 110.
13. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2003). Treatment of tuberculosis (Morbidity and Mortality Weekly Report [MMWR] Publication 52, RR11). Atlanta, GA: Author. Retrieved May 30, 2008, from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5211a1.htm
14. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2005a). Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005 (Morbidity and Mortality Weekly Report [MMWR] Publication 54, RR17). Atlanta, GA: Author. Retrieved February 4, 2009, from http://www.cdc.gov/mmwr/preview/mmwrhtml/ rr5417a1.htm?s-cid=rr5417a1-e
15. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2005b). Guidelines for using the QuantiFERON-TB gold test for detecting Mycobacterium tuberculosis infection, United States (Morbidity and Mortality Weekly Report [MMWR] Publication 54, RR15). Atlanta, GA: Author. Retrieved May 30, 2008, from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5415a4. htm
16. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2007a). Trends in tuberculosis - U.S. 2006 (Morbidity and Mortality Weekly Report [MMWR] Publication 56, 11). Atlanta, GA: Author. Retrieved May 30, 2008, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5611a2. htm
17. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2007b). TB elimination: QuantiFERON-TB gold test. Atlanta, GA: Author. Retrieved January 6, 2008, from http://www.cdc.gov/tb/pubs/ tbfactsheets/QFT.htm
18. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2007c). TB elimination: State TB control offices. Retrieved May 30, 2008, from http://www.cdc.gov/tb/pubs/tbfactsheets/stateTBoffices.pdf
19. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2008a). Trends in tuberculosis - U.S. 2007 (Morbidity and Mortality Weekly Report (MMWR) Publication 57, 11). Atlanta, GA: Author. Retrieved May 30, 2008, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5711a2. htm
20. U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) 2008b). Health information for international travel 2008. Chapter 4: Tuberculosis. Atlanta, GA: Author. Retrieved February 4, 2009, from http://wwwn.cdc.gov/travel/yellowBookCh4-TB.aspx
21. World Health Organization (WHO) 2006). Tuberculosis and air travel: Guidelines for prevention and control (2nd ed.). Retrieved January 6, 2008, from http://whqlibdoc.who.int/hq/2006/WHO-HTM-TB-2006.363-eng.pdf
22. World Health Organization (WHO) 2008). WHO report 2008. Global tuberculosis control report: Surveillance, planning, financing. Author. Retrieved February 4, 2009, from http://www.who.int/tb/publications/global- report/2008/pdf/fullreport.pdf